Immutep
IMMP
21 hedge funds and large institutions have $3.41M invested in Immutep in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 7 closing their positions.
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
12% more call options, than puts
Call options by funds: $372K | Put options by funds: $331K
11% more funds holding
Funds holding: 19 → 21 (+2)
0.2% less ownership
Funds ownership: 0.34% → 0.14% (-0.2%)
31% less capital invested
Capital invested by funds: $4.95M → $3.41M (-$1.54M)
86% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWM
Meridian Wealth Management
Lexington,
Kentucky
|
+$492K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$48.4K |
| 3 |
Two Sigma Investments
New York
|
+$48K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$13.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.11M |
| 2 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$854K |
| 3 |
Millennium Management
New York
|
-$672K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$189K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$156K |
IMMP Hedge Fund Activity: Q2 2023 in Review
21 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q2 2023, worth a combined $3.41M — down 31% from $4.95M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new IMMP positions and 7 closed out — a net gain of 2 holders — while 1 added to existing stakes and 7 trimmed.
The largest buyer was Meridian Wealth Management, opening a new position worth an estimated $492K. The largest seller was Morgan Stanley, cutting an estimated $1.11M.
- 21 institutional investors held Immutep (IMMP) as of Q2 2023, up from 19 in Q1 2023.
- Funds reported $3.41M of Immutep stock for Q2 2023, down 31% quarter-over-quarter.
- 9 funds opened new Immutep positions in Q2 2023 and 7 closed out, a net change of +2 holders.
- The largest Immutep buyer in Q2 2023 was Meridian Wealth Management, an estimated $492K added.
- The largest Immutep seller in Q2 2023 was Morgan Stanley, an estimated $1.11M sold.
Based on aggregated 13F filings for Q2 2023.